[1]
Kensler, T.W.; Wakabayash, N.; Biswal, S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol., 2007, 47, 89-116.
[2]
Wright, V.P.; Reiser, P.J.; Clanton, T.L. Redox modulation of global phosphatase activity and protein phosphorylation in intact skeletal muscle. J. Physiol., 2009, 587(23), 5767-5781.
[3]
Finkel, T. Signal transduction by reactive oxygen species. J. Cell Biol., 2011, 194, 7-15.
[4]
Gajewski, E.; Rao, G.; Nackerdien, Z.; Dizdaroglu, M. Modification of DNA bases in mammalian chromatin by radiation-generated free radicals. Biochemistry, 1990, 29, 7876-7882.
[5]
Brown, D.I.; Griendling, K.K. Nox proteins in signal transduction. Free Radic. Biol. Med., 2009, 47, 1239-1253.
[6]
Aguirre, J.; Lambeth, J.D. Nox enzymes from fungus to fly to fish and what they tell us about nox function in mammals. Free Radic. Biol. Med., 2010, 49, 1342-1353.
[7]
Dziedzic, A.; Kubina, R.; Bułdak, R.J.; Skonieczna, M.; Cholewa, K. Silver nanoparticles exhibit the dose-dependent anti-proliferative effect against human squamous carcinoma cells attenuated in the presence of berberine. Molecules, 2016, 21(3), 365.
[8]
Ho, Y.T.; Lu, C.C.; Yang, J.S.; Chiang, J.H.; Li, T.C.; Ip, S.W.; Hsia, T.C.; Liao, C.L.; Lin, J.G.; Wood, W.G.; Chung, J.G. Berberine induced apoptosis via promoting the expression of caspase-8, -9 and -3, apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res., 2009, 29(10), 4063-4070.
[9]
Ho, Y.T.; Yang, J.S.; Li, T.C.; Lin, J.J.; Lin, J.G.; Lai, K.C.; Ma, C.Y.; Wood, W.G.; Chung, J.G. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-κB, u-PA and MMP-2 and -9. Cancer Lett., 2009, 279(2), 155-162.
[10]
Seo, Y.S.; Yim, M.J.; Kim, B.H.; Kang, K.R.; Lee, S.Y.; Oh, J.S.; You, J.S.; Kim, S.G.; Yu, S.J.; Lee, G.J.; Kim, D.K.; Kim, C.S.; Kim, J.S.; Kim, J.S. Berberine-induced anticancer activities in FaDu head and neck squamous cell carcinoma cells. Oncol. Rep., 2015, 25, 3025-3034.
[11]
Xie, J.; Xu, Y.; Huang, X.; Chen, Y.; Fu, J.; Xi, M.; Wang, L. Berberine-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species generation and mitochondrial-related apoptotic pathway. Tumour Biol., 2015, 36, 1279-1288.
[12]
Tan, W.; Zhong, Z.; Wang, S.; Suo, Z.; Yang, X.; Hu, X.; Wang, Y. Berberine regulated lipid metabolism in the presence of C75,
compound C, and TOFA in breast cancer cell line MCF-7.Evid.-
Based Compl. Alt. Med; , 2015, p. Article ID 396035, 10 pages.
[13]
Rello-Varona, S.; Kepp, O.; Vitale, I.; Michaud, M.; Senovilla, L.; Jemaa, M.; Joza, N.; Galluzzi, L.; Castedo, M.; Kroemer, G. An automated fluorescence videomicroscopy assay for the detection of mitotic catastrophe. Cell Death Dis., 2010, 1e25
[14]
Xia, N.; Daiber, A.; Habermeier, A.; Closs, E.I.; Thum, T.; Spanier, G.; Lu, Q.; Oelze, M.; Torzewski, M.; Lackner, K.J.; Munzel, T.; Forstermann, U.; Li, H. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in Apolipoprotein E knockout mice. J. Pharmacol. Exp. Ther., 2010, 335(1), 149-154.
[15]
Flores-Pérez, A.; Elizondo, G. Apoptosis induction and inhibition of HeLa cell proliferation by alpha-naphthoflavone and resveratrol are aryl hydrocarbon receptor-independent. Chem. Biol. Interact., 2018, 281, 98-105.
[16]
Tomas-Hernández, S.; Blanco, J.; Rojas, C.; Roca Martínez, J.; Ojeda Montes, M.J.; Beltrán Debón, R.; Garcia Vallvé, S.; Pujadas, G.; Arola, L.; Mulero, M. Resveratrol potently counteracts quercetin starvation induced autophagy and sensitizes HepG2 cancer cells to apoptosis. Mol. Nutr. Food Res., 2018, 62, 1-13.
[17]
Truong, V.L.; Jun, M.; Jeong, W.S. Role of resveratrol in regulation of cellular defense systems against oxidative stress. Biofactors, 2017, 44(1), 36-49.
[18]
Zhou, X.; Chen, M.; Zeng, X.; Yang, J.; Deng, H.; Yi, L.; Mi, M.T. Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells. Cell Death Dis., 2014, 5e1576
[19]
Zheng, X.; Jia, B.; Tian, X.T.; Song, X.; Wu, M.L.; Kong, Q.Y.; Li, H.; Liu, J. Correlation of reactive oxygen species levels with resveratrol sensitivities of anaplastic thyroid cancer cells. Oxid. Med. Cell. Longev., 2018. Article ID 6235417
[20]
Molavian, H.R.; Goldman, A.; Phipps, C.J.; Kohandel, M.; Wouters, B.G.; Sengupta, S.; Sivaloganathan, S. Drug-induced reactive oxygen species (ROS) rely on cell membrane properties to exert anticancer effects. Sci. Rep., 2016, 6, 27439.
[21]
Peng, L.; Kang, S.; Yin, Z.; Jia, R.; Song, X.; Li, L.; Li, Z.; Zou, Y.; Liang, X.; Li, L.; He, C.; Ye, G.; Yin, L.; Shi, F.; Lv, C.; Jing, B. Antibacterial activity and mechanism of berberine against Streptococcus agalactiae. Int. J. Clin. Exp. Pathol., 2015, 8(5), 5217-5223.
[22]
Hwang, D.; Lim, Y.H. Resveratrol antibacterial activity against Escherichia coli is mediated by Z-ring formation inhibition via suppression of FtsZ expression. Sci. Rep., 2015, 5, 2-11.
[23]
Paulo, L.; Oleastro, M.; Gallardo, E.; Queiroz, J.A.; Domingues, F. Antimicrobial properties of resveratrol: A review In:Science
against Microbial Pathogens: Communicating Current Research
and Technological Advances; Mendez-Vilas A., Ed.; Formatex:
Sain,. , 2011, Vol. 2, pp. 1225-1235.
[24]
Falchetti, R.; Fuggetta, M.P.; Lanzilli, G.; Tricarico, M.; Ravagnan, G. Effect of resveratrol on human immune cell function. Life Sci., 2001, 70(1), 81-96.
[25]
Leischner, C.; Burkard, M.; Pfeiffer, M.M.; Lauer, U.M.; Busch, C.; Venturelli, S. Nutritional immunology: Function of natural killer cells and their modulation by resveratrol for cancer prevention and treatment. Nutr. J., 2016, 15(1), 47.
[26]
Zou, K.; Li, Z.; Zhang, Y.; Zhang, H.Y.; Li, B.; Zhu, W.L.; Shi, J.Y.; Jia, Q.; Li, Y.M. Advances in the study of berberine and its derivatives: A focus on anti-inflammatory and anti-tumor effects in the digestive system. Acta Pharmacol. Sin., 2017, 38(2), 157-167.
[27]
Jones, D.P.; Sies, H. The redox code. Antioxid. Redox Signal., 2015, 23(9), 734-746.
[28]
Collet, J-F.; Messens, J. Structure, function, and mechanism of thioredoxin proteins. Antioxid. Redox Signal., 2010, 13(8), 1205-1216.
[29]
Roh, J.L.; Jang, H.; Kim, E.H.; Shin, D. Targeting of the glutathione, thioredoxin, and Nrf2 antioxidant systems in head and neck cancer. Antioxid. Redox Signal., 2017, 27(2), 106-114.
[30]
Jun, S.; Dory, L. Allele-specific effects on extracellular superoxide dismutase synthesis and secretion. J. Biomed. Sci. Eng., 2017, 10(4), 135-148.
[31]
Saenko, Y.; Cieślar-Pobuda, A.; Skonieczna, M.; Rzeszowska-Wolny, J. Changes of reactive oxygen and nitrogen species and mitochondrial functioning in human K562 and HL60 cells exposed to ionizing radiation. Radiat. Res., 2013, 180(4), 360-366.
[32]
Muzza, M.; Fugazzola, L. Disorders of H2O2 generation. Best Pract. Res. Clin. Endocrinol. Metab., 2017, 31(2), 225-240.
[33]
Lennicke, C.; Rahn, J.; Lichtenfels, R.; Wessjohann, L.A.; Seliger, B. Hydrogen peroxide - Production, fate and role in redox signaling of tumor cells. Cell Commun. Signal., 2015, 13(1), 1-19.
[34]
Altenhöfer, S.; Radermacher, K.A.; Kleikers, P.W.M.; Wingler, K.; Schmidt, H.H. Evolution of NADPH oxidase inhibitors: Selectivity and mechanisms for target engagement. Antioxid. Redox Signal., 2015, 23(5), 406-427.
[35]
Boncel, S.B.; Pluta, A.; Skonieczna, M.; Gondela, A.; Maciejewska, B.; Herman, A.P.; Jędrysiak, R.G.; Budniok, S.; Komedera, K.; Blachowski, A.; Walczak, K.Z. Hybrids of iron-filled multiwall carbon nanotubes and anticancer agents as potential magnetic drug delivery systems: In vitro studies against human melanoma, colon carcinoma, and colon adenocarcinoma. J. Nanomater., 2017.Article ID 1262309
[36]
Griner, L.A.M.; Guha, R.; Shinn, P.; Young, R.M.; Keller, J.M.; Liu, D.; Goldlust, I.S.; Yasgar, A.; McKnight, C.; Boxer, M.B.; Duveau, D.Y.; Jiang, J.K.; Michael, S.; Mierzwa, T.; Huang, W.; Walsh, M.J.; Mott, B.T.; Patel, P.; Leister, W.; Maloney, D.J.; Leclair, C.A.; Rai, G.; Jadhav, A.; Peyser, B.D.; Austin, C.P.; Martin, S.E.; Simeonov, A.; Ferrer, M.; Staudt, L.M.; Thomas, C.J. High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell–like diffuse large B-cell lymphoma cells. Proc. Natl. Acad. Sci. USA, 2014, 111(6), 2349-2354.
[37]
Tallarida, R.J. Drug synergism: Its detection and applications. J. Pharmacol. Exp. The., 2001, 298(3), 865-872.
[38]
Tallarida, R.J. An overview of drug combination analysis with isobolograms. J. Pharmacol. Exp. The., 2006, 319(1), 1-7.
[39]
Bishayee, A.; Block, K. A broad-spectrum integrative design for cancer prevention and therapy. Semin. Cancer Biol., 2015, 35, S276-S304.
[40]
Wang, K.; Zhang, C.; Bao, J.; Jia, X.; Liang, Y.; Wang, X.; Chen, M.; Su, H.; Li, P.; Wan, J.B.; He, C. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci. Rep., 2016, 6, 26064.
[41]
Zhao, Y.; Jing, Z.; Li, Y.; Mao, W. Berberine in combination with cisplatin suppresses breast cancer cell growth through induction of DNA breaks and caspase-3-dependent apoptosis. Oncol. Rep., 2016, 36, 567-572.
[42]
Pan, Y.; Zhang, F.; Zhao, Y.; Shao, D.; Zheng, X.; Chen, Y.; He, K.; Li, J.; Chen, L. Berberine enhances chemosensitivity and induces apoptosis through dose-orchestrated AMPK signaling in breast cancer. J. Cancer, 2017, 8(9), 1679-1689.
[43]
Langcake, P.; Pryce, R. The production of resveratrol by Vitis vinifera and other members of the vitaceae as a response to infection or injury. Physiol. Plant Pathol., 1976, 9, 77-86.
[44]
Meng, J.; Guo, F.; Xu, H.; Liang, W.; Wang, C.; Yang, X.D. Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo. Sci. Rep., 2016, 6, 22390.
[45]
Wang, G.; Guo, X.; Chen, H.; Lin, T.; Xu, Y.; Chen, Q.; Liu, J.; Zeng, J.; Zhang, X.K.; Yao, X. A resveratrol analog, Phoyunbene B, induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells. Bioorg. Med. Chem. Lett., 2012, 22(5), 2114-2118.
[46]
Yu, X.D.; Yang, J.L.; Zhang, W.L.; Liu, D.X. Resveratrol inhibits oral squamous cell carcinoma through induction of apoptosis and G2/M phase cell cycle arrest. Tumour Biol., 2016, 37(3), 2871-2877.
[47]
Wang, B.; Liu, J.; Gong, Z. Resveratrol induces apoptosis in K562 cells via the regulation of mitochondrial signaling pathways. Int. J. Clin. Exp. Med., 2015, 8(9), 16926-16933.
[48]
da Costa Araldi, I.C.; Bordin, F.P.R.; Cadoná, F.C.; Barbisan, F.; Azzolin, V.F.; Teixeira, C.F.; da Cruz, I.B.M.; Baumhardt, T.; Duarte, M.M.M.F.; Bauermann, L.D.F. The in vitro radiosensitizer potential of resveratrol on MCF-7 breast cancer cells. Chem. Biol. Interact., 2018, 282, 85-92.
[49]
Flores-Pérez, A.; Elizondo, G. Apoptosis induction and inhibition of HeLa cell proliferation by alpha-naphthoflavone and resveratrol are aryl hydrocarbon receptor-independent. Chem. Biol. Interact., 2018, 281, 98-105.
[50]
Wang, W.; Li, P.; Xu, J.; Wu, X.; Guo, Z.; Fan, F.; Song, R.; Wang, J.; Wei, L.; Teng, H. Resveratrol attenuates high glucose-induced nucleus pulposus cell apoptosis and senescence through activating the ROS-mediated PI3K/Akt pathway. Biosci. Rep., 2018, 38(2)BSR20171454
[51]
Jara, P.; Spies, J.; Cárcamo, C.; Arancibia, Y.; Vargas, G.; Martin, C.; Salas, M.; Otth, C.; Zambrano, A. The effect of resveratrol on cell viability in the Burkitt’s lymphoma cell line Ramos. Molecules, 2017, 23(1), 14.
[52]
Frendo-Cumbo, S.; Macpherson, R.; Wright, D. Beneficial effects of combined resveratrol and metformin therapy in treating diet-induced insulin resistance. Physiol. Rep., 2016, 4(15), 1-12.
[53]
Almajdoob, S.; Hossain, E.; Anand-Srivastava, M. Resveratrol attenuates hyperproliferation of vascular smooth muscle cells from spontaneously hypertensive rats: Role of ROS and ROS-mediated cell signaling. Vascul. Pharmacol., 2017, 101, 48-56.
[54]
Calabrese, E.J.; Mattson, M.P.; Calabrese, V. Resveratrol commonly displays hormesis: occurrence and biomedical significance. Hum. Exp. Toxicol., 2010, 29(12), 980-1015.
[55]
Borriello, A.; Bencivenga, D.; Caldarelli, I.; Tramontano, A.; Borgia, A.; Prozzi, A.V.; Oliva, A.; DellaRagione, F. Resveratrol and cancer treatment: Is hormesis a yet unsolved matter. Curr. Pharm. Des., 2013, 19(30), 5384-5393.
[56]
Bao, J.; Huang, B.; Zou, L.; Chen, S.; Zhang, C.; Zhang, Y.; Chen, M.; Wan, J.B.; Su, H.; Wang, Y.; He, C. Hormetic effect of berberine attenuates the anticancer activity of chemotherapeutic agents. PLoS One, 2015, 10(9)e0139298
[57]
Gambini, J.; Inglés, M.; Olaso, G.; Lopez-Grueso, R.; Bonet-Costa, V.; Gimeno-Mallench, L.; Mas-Bargues, C.; Abdelaziz, K.M.; Gomez-Cabrera, M.C.; Vina, J.; Borras, C. Properties of resveratrol: In vitro and in vivo studies about metabolism, bioavailability, and biological effects in animal models and humans. Oxid. Med. Cell. Longev., 2015.837042
[58]
Sun, Y.; Jin, C.; Zhang, X.; Jia, W.; Le, J.; Ye, J. Restoration of GLP-1 secretion by Berberine is associated with protection of colon enterocytes from mitochondrial overheating in diet-induced obese mice. Nutr. Diabetes, 2018, 8, 53.
56
2
1
1